Biological and Pharmaceutical Bulletin · 2012 · 22 citations · 30 references
MedicineMedicinal ChemistryPharmacologyCancer PharmacologyDrug DiscoveryMolecular OncologyMedicinal PlantsOncology PharmacologyAnticancer ActivityAnticancer Compound ScreeningAnticancer Natural ProductsBioactive Plant CompoundsCancer Cell Proliferation InhibitionPharmacological ScreeningPlant AlkaloidsTumor Cell Proliferation
Activity-guided fractionation of an 80% EtOH extract from the aerial parts of Saururus chinensis led to isolation of three anti-proliferative neolignans (1-3) along with four flavonoids (4-7) and four aristolactams (8-11). Their chemical structures were identified by analysis of spectroscopic data. All compounds 1-11 were evaluated for their activities against 28 human cancer cell lines using an in vitro cell proliferation assay. Compounds 1-3 showed potent anti-proliferative activities against cervical (C33a, IC50=0.01 µM for 1; 0.28 µM for 2; 2.80 µM for 3) and lung (NCI-H460, IC50=0.05 µM for 1; 1.37 µM for 2; 6.46 µM for 3) cancer cells without any remarkable cytotoxic effects on human normal lung cells as a control. Taken together, these data demonstrated the identification of anti-proliferative neolignans which are active components of S. chinensis.
30
Ae Kyung Lee, Sang Hyun Sung, Young Choong Kim et al. · British Journal of Pharmacology · 2003 · 276 citations · Full text
Bioactive aristolactams from Piper umbellatum
Turibio Kuiate Tabopda, Joseph Ngoupayo, Jiawei Liu et al. · Phytochemistry · 2008 · 113 citations
Rat lens aldose reductase inhibitory constituents of <i>Nelumbo nucifera</i> stamens
Soon Sung Lim, Yu Jung Jung, Sook Kyung Hyun et al. · Phytotherapy Research · 2006 · 107 citations · Full text
Complex flavonol glycosides from the leaves of Ginkgo biloba
A. Hasler, Gian‐Andrea Gross, Beat H. Meier et al. · Phytochemistry · 1992 · 98 citations